Institute of Chemical Technology (ICT), Mumbai has received a prestigious grant from Bill & Melinda Gates Foundation to develop the first green nanovaccine for nasal immunization against brucellosis. Prof. Vandana Patravale, ICT, Matunga was awarded USD100,000 in phase I of Grand Challenges Explorations Round 11 for developing the cost-effective vaccine technology from over 2700 applications. The sub-unit nanovaccine aims to confer long term protective immunity to humans and livestock population. Currently, Brucellosis is a zoonotic bacterial infection with a potential to be exploited as a bioweapon, and currently no human vaccine is available for treatment
Roselabs Bioscience Ltd and Roselabs Polymers Ltd is planning to invest Rs. 4000 million to manufacture pre-filled syringes in India. The method of using pre-filled syringe is designed to provide assured sterility, safety, convenience, greater accuracy, minimal over-filling, least medical waste, freedom from needle phobia and least chances of accidental needle stick injuries. The company has the capacity to manufacture 8 lakh syringes daily. Currently, 95% of pre-filled syringes are imported.Latest News :
The company is in the process of raising Rs. 1000 million towards private equity placements and venture capital
Indo Phyto Chemicals is to expand its bulk drug unit in Shakanpur in Pirumadara in Nainital in Uttarakhand with an investment of Rs. 50 million. The project involves expanding its bulk drug unit to produce Estradiol, Levonorgestrel, Norethisterone, Allylestrenol, Lynestrenol, Nandrolone Decanoate, ThiopentalSodium, Spironolactone, Solnaftate,Disulfiram etc., and will have a total capacity of 140000 kg /year .